| Year |
Citation |
Score |
| 2022 |
Sablatura LK, Tellman TV, Kim A, Farach-Carson MC. Bone Marrow Endothelial Cells Increase Prostate Cancer Cell Apoptosis in 3D Triculture Model of Reactive Stroma. Biology. 11. PMID 36138750 DOI: 10.3390/biology11091271 |
0.324 |
|
| 2020 |
Brasil da Costa FH, Lewis MS, Truong A, Carson DD, Farach-Carson MC. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models. Plos One. 15: e0230354. PMID 32413029 DOI: 10.1371/Journal.Pone.0230354 |
0.413 |
|
| 2020 |
Cruz LA, Tellman TV, Farach-Carson MC. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1245: 133-146. PMID 32266656 DOI: 10.1007/978-3-030-40146-7_6 |
0.369 |
|
| 2020 |
Pan T, Martinez M, Hubka KM, Song JH, Lin SC, Yu G, Lee YC, Gallick GE, Tu SM, Harrington DA, Farach-Carson MC, Lin SH, Satcher RL. Cabozantinib Reverses Renal Cell Carcinoma-Mediated Osteoblast Inhibition in Three-Dimensional Co-culture In Vitro and Reduces Bone Osteolysis In Vivo. Molecular Cancer Therapeutics. PMID 32220969 DOI: 10.1158/1535-7163.Mct-19-0174 |
0.393 |
|
| 2020 |
Cruz LA, Tellman TV, Grindel BJ, Carson DD, Farach-Carson MC. Abstract 2608: MMP-7 increases migration by decreasing intercellular E-cadherin and F-actin localization in prostate cancer micro-tumors formed by perlecan/HSPG2 Cancer Research. 80: 2608-2608. DOI: 10.1158/1538-7445.Am2020-2608 |
0.367 |
|
| 2019 |
Wu D, Witt RL, Harrington DA, Farach-Carson MC. Dynamic Assembly of Human Salivary Stem/Progenitor Microstructures Requires Coordinated αβ Integrin-Mediated Motility. Frontiers in Cell and Developmental Biology. 7: 224. PMID 31750298 DOI: 10.3389/Fcell.2019.00224 |
0.34 |
|
| 2019 |
Pei S, Parthasarathy S, Parajuli A, Martinez J, Lv M, Jiang S, Wu D, Wei S, Lu XL, Farach-Carson MC, Kirn-Safran CB, Wang L. Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading. Bone. 115078. PMID 31715337 DOI: 10.1016/J.Bone.2019.115078 |
0.317 |
|
| 2019 |
Cruz LA, Tellman TV, Farach-Carson MC, Grindel B, Carson DD. Abstract 67: MMP-7 decreases E-cadherin localization at cell-cell contacts resulting in F-actin cytoskeletal remodeling in prostate cancer micro-tumors formed by perlecan/HSPG2 Cancer Research. 79: 67-67. DOI: 10.1158/1538-7445.Sabcs18-67 |
0.375 |
|
| 2018 |
Wu D, Chapela P, Farach-Carson MC. Reassembly of Functional Human Stem/Progenitor Cells in 3D Culture. Methods in Molecular Biology (Clifton, N.J.). 1817: 19-32. PMID 29959699 DOI: 10.1007/978-1-4939-8600-2_3 |
0.382 |
|
| 2018 |
Grindel BJ, Martinez JR, Tellman TV, Harrington DA, Zafar H, Nakhleh L, Chung LW, Farach-Carson MC. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells. Scientific Reports. 8: 7262. PMID 29740048 DOI: 10.1038/S41598-018-25435-3 |
0.384 |
|
| 2018 |
Sablatura L, Bircsak KM, Farach-Carson MC, Navone N, Shepherd P, Zarembinski T, Constantinou PE, Saleh A, Harrington DA. Abstract 5023: A 3D perfusable platform for high-throughput screening diverse racial/ethnic prostate cancer specimens Cancer Research. 78: 5023-5023. DOI: 10.1158/1538-7445.Am2018-5023 |
0.391 |
|
| 2018 |
Costa FHBd, Navone NM, Farach-Carson MC, Carson DD. Abstract 3799: Heparan sulfate modifiers and signaling between tumor-associated macrophages and cancer-associated fibroblasts in a biomimetic hydrogel model of bone-metastatic prostate cancer Cancer Research. 78: 3799-3799. DOI: 10.1158/1538-7445.Am2018-3799 |
0.396 |
|
| 2017 |
Farach-Carson MC, Lin SH, Nalty T, Satcher RL. Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? Frontiers in Oncology. 7: 163. PMID 28824875 DOI: 10.3389/Fonc.2017.00163 |
0.342 |
|
| 2017 |
Ozdemir T, Srinivasan PP, Zakheim DR, Harrington DA, Witt RL, Farach-Carson MC, Jia X, Pradhan-Bhatt S. Bottom-up assembly of salivary gland microtissues for assessing myoepithelial cell function. Biomaterials. 142: 124-135. PMID 28734180 DOI: 10.1016/J.Biomaterials.2017.07.022 |
0.373 |
|
| 2017 |
Srinivasan PP, Patel VN, Liu S, Harrington DA, Hoffman MP, Jia X, Witt RL, Farach-Carson MC, Pradhan-Bhatt S. Primary Salivary Human Stem/Progenitor Cells Undergo Microenvironment-Driven Acinar-Like Differentiation in Hyaluronate Hydrogel Culture. Stem Cells Translational Medicine. 6: 110-120. PMID 28170182 DOI: 10.5966/Sctm.2016-0083 |
0.357 |
|
| 2017 |
Wang Z, Pradhan-Bhatt S, Farach-Carson MC, Passineau MJ. Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells. Journal of Dental Research. 22034516685045. PMID 28072927 DOI: 10.1177/0022034516685045 |
0.32 |
|
| 2017 |
Sablatura LK, Harrington DA, Farach-Carson MC. Abstract 5779: Building a novel 3D hyaluronan-based tri-culture model of the bone metastatic microenvironment for cancer studies Cancer Research. 77: 5779-5779. DOI: 10.1158/1538-7445.Am2017-5779 |
0.374 |
|
| 2017 |
Costa FHBd, Navone NM, Farach-Carson MC, Carson DD. Abstract 4626: Macrophages alter heparan sulfate-modifying enzyme levels, growth factor activity and cancer cell growth in 3D hydrogels Immunology. 77: 4626-4626. DOI: 10.1158/1538-7445.Am2017-4626 |
0.341 |
|
| 2016 |
Ozdemir T, Fowler EW, Liu S, Harrington DA, Witt RL, Farach-Carson MC, Pradhan-Bhatt S, Jia X. Tuning Hydrogel Properties to Promote the Assembly of Salivary Gland Spheroids in 3D. Acs Biomaterials Science & Engineering. 2: 2217-2230. PMID 27990487 DOI: 10.1021/Acsbiomaterials.6B00419 |
0.364 |
|
| 2016 |
Chiu YC, Fong EL, Grindel BJ, Kasper FK, Harrington DA, Farach-Carson MC. Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration. Journal of Experimental Orthopaedics. 3: 25. PMID 27714703 DOI: 10.1186/S40634-016-0057-1 |
0.346 |
|
| 2016 |
Fong EL, Harrington DA, Farach-Carson MC, Yu H. Heralding a new paradigm in 3D tumor modeling. Biomaterials. 108: 197-213. PMID 27639438 DOI: 10.1016/J.Biomaterials.2016.08.052 |
0.325 |
|
| 2016 |
Farach A, Ding Y, Lee M, Creighton C, Delk NA, Ittmann M, Miles B, Rowley D, Farach-Carson MC, Ayala GE. Neuronal trans-differentiation in prostate cancer cells. The Prostate. PMID 27403603 DOI: 10.1002/Pros.23221 |
0.329 |
|
| 2016 |
Albritton JL, Roybal JD, Paulsen SJ, Calafat N, Flores-Zaher JA, Farach-Carson MC, Gibbons DL, Miller JS. Ultrahigh-throughput Generation and Characterization of Cellular Aggregates in Laser-ablated Microwells of Poly(dimethylsiloxane). Rsc Advances. 6: 8980-8991. PMID 26998251 DOI: 10.1039/C5Ra26022A |
0.349 |
|
| 2016 |
Grindel B, Li Q, Arnold R, Petros J, Zayzafoon M, Muldoon M, Stave J, Chung LW, Farach-Carson MC. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget. PMID 26862737 DOI: 10.18632/Oncotarget.7197 |
0.308 |
|
| 2016 |
Sablatura LK, Kavuri M, Richards P, Harrington DA, Ellis MJ, Farach-Carson MC. Abstract B30: Ex vivo culture of breast cancer patient-derived xenografts in modified 3-D hyaluronan hydrogels Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B30 |
0.374 |
|
| 2016 |
Constantinou PE, Engel BJ, Sablatura LK, Doty NJ, Carson DD, Farach-Carson MC, Harrington DA, Zarembinski TI. Abstract 604: A multi-layered, hydrogel system for automated 3D high throughput drug screening of cancer-stromal cell co-cultures Cancer Research. 76: 604-604. DOI: 10.1158/1538-7445.Am2016-604 |
0.385 |
|
| 2016 |
Brasil FH, Ferrer V, Navone NM, Farach-Carson MC, Carson DD. Abstract 5102: Heparan sulfate modifying enzymes deliver cancer, stromal and macrophage-produced heparin-binding growth factors in the prostate cancer microenvironment Cancer Research. 76: 5102-5102. DOI: 10.1158/1538-7445.Am2016-5102 |
0.39 |
|
| 2016 |
Grindel BJ, Martinez J, Zafar H, Nakhleh LK, Chung LWK, Farach-Carson MC. Abstract 1563: Interplay between perlecan/HSPG2 and matrilysin/MMP-7 in the prostate cancer tumor microenvironment directs metastatic programming through focal adhesion kinase and FoxM1 Cancer Research. 76: 1563-1563. DOI: 10.1158/1538-7445.Am2016-1563 |
0.303 |
|
| 2015 |
Fong EL, Wan X, Yang J, Morgado M, Mikos AG, Harrington DA, Navone NM, Farach-Carson MC. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Biomaterials. 77: 164-172. PMID 26599623 DOI: 10.1016/J.Biomaterials.2015.10.059 |
0.431 |
|
| 2015 |
Wijeratne SS, Martinez JR, Grindel BJ, Frey EW, Li J, Wang L, Farach-Carson MC, Kiang CH. Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 26546708 DOI: 10.1016/J.Matbio.2015.11.001 |
0.304 |
|
| 2015 |
Engel BJ, Constantinou PE, Sablatura LK, Doty NJ, Carson DD, Farach-Carson MC, Harrington DA, Zarembinski TI. Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. Advanced Healthcare Materials. PMID 26059746 DOI: 10.1002/Adhm.201500258 |
0.39 |
|
| 2015 |
Pan T, Fong EL, Martinez M, Harrington DA, Lin SH, Farach-Carson MC, Satcher RL. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases. Cancer Letters. 365: 89-95. PMID 26004343 DOI: 10.1016/J.Canlet.2015.05.019 |
0.401 |
|
| 2015 |
Grigore AD, Ben-Jacob E, Farach-Carson MC. Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? Frontiers in Oncology. 5: 37. PMID 25785244 DOI: 10.3389/Fonc.2015.00037 |
0.349 |
|
| 2015 |
Chang M, Morgado M, Patel V, Gwede M, Farach-Carson MC, Delk N. Abstract B15: Bone marrow stromal cell-secreted inflammatory cytokines promote treatment resistance and survival of prostate cancer cells Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B15 |
0.398 |
|
| 2014 |
Xu X, Farach-Carson MC, Jia X. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnology Advances. 32: 1256-68. PMID 25116894 DOI: 10.1016/J.Biotechadv.2014.07.009 |
0.399 |
|
| 2014 |
Chang MA, Patel V, Gwede M, Morgado M, Tomasevich K, Fong EL, Farach-Carson MC, Delk NA. IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells. Journal of Cellular Biochemistry. 115: 2188-97. PMID 25103771 DOI: 10.1002/Jcb.24897 |
0.332 |
|
| 2014 |
Grindel BJ, Martinez JR, Pennington CL, Muldoon M, Stave J, Chung LW, Farach-Carson MC. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biology : Journal of the International Society For Matrix Biology. 36: 64-76. PMID 24833109 DOI: 10.1016/J.Matbio.2014.04.005 |
0.347 |
|
| 2014 |
Lowe DA, Lepori-Bui N, Fomin PV, Sloofman LG, Zhou X, Farach-Carson MC, Wang L, Kirn-Safran CB. Deficiency in perlecan/HSPG2 during bone development enhances osteogenesis and decreases quality of adult bone in mice. Calcified Tissue International. 95: 29-38. PMID 24798737 DOI: 10.1007/S00223-014-9859-2 |
0.323 |
|
| 2014 |
Fong EL, Martinez M, Yang J, Mikos AG, Navone NM, Harrington DA, Farach-Carson MC. Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening. Molecular Pharmaceutics. 11: 2040-50. PMID 24779589 DOI: 10.1021/Mp500085P |
0.391 |
|
| 2014 |
Warren CR, Grindel BJ, Francis L, Carson DD, Farach-Carson MC. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment. Journal of Cellular Biochemistry. 115: 1322-33. PMID 24700612 DOI: 10.1002/Jcb.24788 |
0.406 |
|
| 2014 |
Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M, Andersson R, Mungall CJ, Meehan TF, Schmeier S, ... ... Farach-Carson MC, et al. A promoter-level mammalian expression atlas. Nature. 507: 462-70. PMID 24670764 DOI: 10.1038/Nature13182 |
0.345 |
|
| 2014 |
Chu GC, Zhau HE, Wang R, Rogatko A, Feng X, Zayzafoon M, Liu Y, Farach-Carson MC, You S, Kim J, Freeman MR, Chung LW. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocrine-Related Cancer. 21: 311-26. PMID 24478054 DOI: 10.1530/Erc-13-0548 |
0.389 |
|
| 2014 |
Xu X, Sabanayagam CR, Harrington DA, Farach-Carson MC, Jia X. A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials. 35: 3319-30. PMID 24447463 DOI: 10.1016/J.Biomaterials.2013.12.080 |
0.354 |
|
| 2014 |
Dicker KT, Gurski LA, Pradhan-Bhatt S, Witt RL, Farach-Carson MC, Jia X. Hyaluronan: a simple polysaccharide with diverse biological functions. Acta Biomaterialia. 10: 1558-70. PMID 24361428 DOI: 10.1016/J.Actbio.2013.12.019 |
0.731 |
|
| 2014 |
Chang MA, Morgado M, Warren CR, Hinton CV, Farach-Carson MC, Delk NA. p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines. The Prostate. 74: 149-63. PMID 24122957 DOI: 10.1002/Pros.22737 |
0.371 |
|
| 2014 |
Wang B, Lai X, Price C, Thompson WR, Li W, Quabili TR, Tseng WJ, Liu XS, Zhang H, Pan J, Kirn-Safran CB, Farach-Carson MC, Wang L. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 878-91. PMID 24115222 DOI: 10.1002/Jbmr.2105 |
0.329 |
|
| 2014 |
Farach-Carson MC, Warren CR, Harrington DA, Carson DD. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biology : Journal of the International Society For Matrix Biology. 34: 64-79. PMID 24001398 DOI: 10.1016/J.Matbio.2013.08.004 |
0.319 |
|
| 2014 |
Pradhan-Bhatt S, Harrington DA, Duncan RL, Farach-Carson MC, Jia X, Witt RL. A novel in vivo model for evaluating functional restoration of a tissue-engineered salivary gland. The Laryngoscope. 124: 456-61. PMID 23832678 DOI: 10.1002/Lary.24297 |
0.368 |
|
| 2014 |
Fong ELS, Martinez M, Yang J, Chung LMK, Mikos AG, Navone NM, Harrington DA, Farach-Carson MC. Abstract 2030: Culturing patient-derived prostate cancer xenografts using a three-dimensional hydrogel system for drug testing and mechanistic studies Cancer Research. 74: 2030-2030. DOI: 10.1158/1538-7445.Am2014-2030 |
0.432 |
|
| 2013 |
Chen J, Lobachev KS, Grindel BJ, Farach-Carson MC, Hyzy SL, El-Baradie KB, Olivares-Navarrete R, Doroudi M, Boyan BD, Schwartz Z. Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3. Molecular Endocrinology (Baltimore, Md.). 27: 1065-77. PMID 23660595 DOI: 10.1210/Me.2012-1277 |
0.344 |
|
| 2013 |
Fong EL, Lamhamedi-Cherradi SE, Burdett E, Ramamoorthy V, Lazar AJ, Kasper FK, Farach-Carson MC, Vishwamitra D, Demicco EG, Menegaz BA, Amin HM, Mikos AG, Ludwig JA. Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proceedings of the National Academy of Sciences of the United States of America. 110: 6500-5. PMID 23576741 DOI: 10.1073/Pnas.1221403110 |
0.43 |
|
| 2013 |
Pradhan-Bhatt S, Harrington DA, Duncan RL, Jia X, Witt RL, Farach-Carson MC. Implantable three-dimensional salivary spheroid assemblies demonstrate fluid and protein secretory responses to neurotransmitters. Tissue Engineering. Part A. 19: 1610-20. PMID 23442148 DOI: 10.1089/Ten.Tea.2012.0301 |
0.376 |
|
| 2012 |
Gurski LA, Xu X, Labrada LN, Nguyen NT, Xiao L, van Golen KL, Jia X, Farach-Carson MC. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. Plos One. 7: e50075. PMID 23166824 DOI: 10.1371/Journal.Pone.0050075 |
0.757 |
|
| 2012 |
Xu X, Gurski LA, Zhang C, Harrington DA, Farach-Carson MC, Jia X. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials. 33: 9049-60. PMID 22999468 DOI: 10.1016/J.Biomaterials.2012.08.061 |
0.752 |
|
| 2012 |
Delk NA, Farach-Carson MC. Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells. Autophagy. 8: 650-63. PMID 22441019 DOI: 10.4161/Auto.19226 |
0.397 |
|
| 2012 |
Gurski LA, Fong ELS, Milton RL, Xu X, Navone N, Jia X, Harrington DA, Farach-Carson MC. Abstract 3206: Three-dimensional hyaluronan hydrogel culture systems facilitate study of the complex microenvironment of bone metastatic prostate cancer cells Cancer Research. 72: 3206-3206. DOI: 10.1158/1538-7445.Am2012-3206 |
0.765 |
|
| 2011 |
Boggs ME, Thompson WR, Farach-Carson MC, Duncan RL, Beebe TP. Co-culture of osteocytes and neurons on a unique patterned surface. Biointerphases. 6: 200-9. PMID 22239813 DOI: 10.1116/1.3664050 |
0.337 |
|
| 2011 |
Warren CR, Catts ZA, Farach-Carson MC. A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin. Experimental Cell Research. 317: 2099-109. PMID 21741379 DOI: 10.1016/J.Yexcr.2011.06.010 |
0.308 |
|
| 2011 |
Thompson WR, Majid AS, Czymmek KJ, Ruff AL, GarcÃa J, Duncan RL, Farach-Carson MC. Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2125-39. PMID 21638318 DOI: 10.1002/Jbmr.437 |
0.333 |
|
| 2011 |
Grindel BJ, Rohe B, Safford SE, Bennett JJ, Farach-Carson MC. Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D₃-MARRS to the nucleus. Journal of Cellular Biochemistry. 112: 2606-15. PMID 21598303 DOI: 10.1002/Jcb.23187 |
0.31 |
|
| 2011 |
Lukianova-Hleb EY, Oginsky AO, Samaniego AP, Shenefelt DL, Wagner DS, Hafner JH, Farach-Carson MC, Lapotko DO. Tunable plasmonic nanoprobes for theranostics of prostate cancer. Theranostics. 1: 3-17. PMID 21547151 DOI: 10.7150/Thno/V01P0003 |
0.308 |
|
| 2011 |
Thompson WR, Modla S, Grindel BJ, Czymmek KJ, Kirn-Safran CB, Wang L, Duncan RL, Farach-Carson MC. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 618-29. PMID 20814969 DOI: 10.1002/Jbmr.236 |
0.309 |
|
| 2011 |
Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, Chung LW, Farach-Carson MC. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. The Prostate. 71: 157-67. PMID 20665531 DOI: 10.1002/Pros.21231 |
0.4 |
|
| 2011 |
Delk NA, Farach-Carson MC. Abstract 3776: Bone marrow stromal cell paracrine signaling and IL-6 induce autophagy in bone metastatic prostate cancer cells Cancer Research. 71: 3776-3776. DOI: 10.1158/1538-7445.Am2011-3776 |
0.384 |
|
| 2010 |
Pradhan S, Farach-Carson MC. Mining the extracellular matrix for tissue engineering applications. Regenerative Medicine. 5: 961-70. PMID 21082894 DOI: 10.2217/Rme.10.61 |
0.515 |
|
| 2010 |
Jha AK, Malik MS, Farach-Carson MC, Duncan RL, Jia X. Hierarchically structured, hyaluronic acid-based hydrogel matrices via the covalent integration of microgels into macroscopic networks. Soft Matter. 6: 5045-5055. PMID 20936090 DOI: 10.1039/C0Sm00101E |
0.318 |
|
| 2010 |
Wagner DS, Delk NA, Lukianova-Hleb EY, Hafner JH, Farach-Carson MC, Lapotko DO. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials. 31: 7567-74. PMID 20630586 DOI: 10.1016/J.Biomaterials.2010.06.031 |
0.346 |
|
| 2010 |
Wang X, Gurski LA, Zhong S, Xu X, Pochan DJ, Farach-Carson MC, Jia X. Amphiphilic Block Co-polyesters Bearing Pendant Cyclic Ketal Groups as Nanocarriers for Controlled Release of Camptothecin. Journal of Biomaterials Science. Polymer Edition. PMID 20594408 DOI: 10.1163/092050610X504260 |
0.696 |
|
| 2010 |
Hartman O, Zhang C, Adams EL, Farach-Carson MC, Petrelli NJ, Chase BD, Rabolt JF. Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. Biomaterials. 31: 5700-18. PMID 20417554 DOI: 10.1016/J.Biomaterials.2010.03.017 |
0.415 |
|
| 2010 |
Sloofman LG, Verdelis K, Spevak L, Zayzafoon M, Yamauchi M, Opdenaker LM, Farach-Carson MC, Boskey AL, Kirn-Safran CB. Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth. Bone. 47: 93-101. PMID 20362701 DOI: 10.1016/J.Bone.2010.03.015 |
0.712 |
|
| 2010 |
Pradhan S, Liu C, Zhang C, Jia X, Farach-Carson MC, Witt RL. Lumen formation in three-dimensional cultures of salivary acinar cells. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 142: 191-5. PMID 20115973 DOI: 10.1016/J.Otohns.2009.10.039 |
0.583 |
|
| 2010 |
Wu W, Beilhartz G, Roy Y, Richard CL, Curtin M, Brown L, Cadieux D, Coppolino M, Farach-Carson MC, Nemere I, Meckling KA. Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Experimental Cell Research. 316: 1101-8. PMID 20064506 DOI: 10.1016/J.Yexcr.2010.01.010 |
0.381 |
|
| 2010 |
Richard CL, Farach-Carson MC, Rohe B, Nemere I, Meckling KA. Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells. Experimental Cell Research. 316: 695-703. PMID 20036234 DOI: 10.1016/J.Yexcr.2009.12.015 |
0.384 |
|
| 2010 |
Gurski LA, Nguyen NT, Golen KCv, Jia X, Farach-Carson MC. Abstract 523: Three-dimensional hyaluronic acid-based hydrogel systems for studies of cancer invasion Cancer Research. 70: 523-523. DOI: 10.1158/1538-7445.Am10-523 |
0.7 |
|
| 2010 |
Delk NA, Diaz AL, Farach-Carson MC. Abstract 4839: Mechanistic regulation of autophagy in the prostate cancer-bone marrow stromal microenvironment Cellular and Molecular Biology. 70: 4839-4839. DOI: 10.1158/1538-7445.Am10-4839 |
0.348 |
|
| 2010 |
Warren CR, Farach-Carson MC, Catts ZA. Abstract 1114: Linker region of the BRCA2 protein increases chemoresistance to cisplatin: Screen for the characterization of cancer-associated variants Cancer Research. 70: 1114-1114. DOI: 10.1158/1538-7445.Am10-1114 |
0.311 |
|
| 2010 |
Gurski LA, Petrelli NJ, Jia X, Farach-Carson MC. 3D Matrices for Anti-Cancer Drug Testing and Development Oncology Issues. 25: 20-25. DOI: 10.1080/10463356.2010.11883480 |
0.69 |
|
| 2010 |
Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC. Corrigendum to "Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells" [Biomaterials. 30 (2009) 6076-6085] (DOI:10.1016/j.biomaterials.2009.07.054) Biomaterials. 31: 4248. DOI: 10.1016/J.Biomaterials.2010.01.141 |
0.735 |
|
| 2009 |
Jha AK, Yang W, Kirn-Safran CB, Farach-Carson MC, Jia X. Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials. 30: 6964-75. PMID 19775743 DOI: 10.1016/J.Biomaterials.2009.09.009 |
0.311 |
|
| 2009 |
Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials. 30: 6076-85. PMID 19695694 DOI: 10.1016/J.Biomaterials.2009.07.054 |
0.761 |
|
| 2009 |
Kirn-Safran C, Farach-Carson MC, Carson DD. Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cellular and Molecular Life Sciences : Cmls. 66: 3421-34. PMID 19629389 DOI: 10.1007/S00018-009-0096-1 |
0.309 |
|
| 2009 |
Hartman O, Zhang C, Adams EL, Farach-Carson MC, Petrelli NJ, Chase BD, Rabolt JF. Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications. Biomacromolecules. 10: 2019-32. PMID 19624098 DOI: 10.1021/Bm8012764 |
0.417 |
|
| 2009 |
O'Connor RD, Zayzafoon M, Farach-Carson MC, Schanen NC. Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone. 45: 346-56. PMID 19414073 DOI: 10.1016/J.Bone.2009.04.251 |
0.619 |
|
| 2009 |
Pradhan S, Zhang C, Jia X, Carson DD, Witt R, Farach-Carson MC. Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro. Tissue Engineering. Part A. 15: 3309-20. PMID 19382872 DOI: 10.1089/Ten.Tea.2008.0669 |
0.558 |
|
| 2009 |
Opdenaker LM, Farach-Carson MC. Rapamycin selectively reduces the association of transcripts containing complex 5' UTRs with ribosomes in C4-2B prostate cancer cells. Journal of Cellular Biochemistry. 107: 473-81. PMID 19347904 DOI: 10.1002/Jcb.22145 |
0.724 |
|
| 2009 |
Shao Y, Czymmek KJ, Jones PA, Fomin VP, Akanbi K, Duncan RL, Farach-Carson MC. Dynamic interactions between L-type voltage-sensitive calcium channel Cav1.2 subunits and ahnak in osteoblastic cells. American Journal of Physiology. Cell Physiology. 296: C1067-78. PMID 19261907 DOI: 10.1152/Ajpcell.00427.2008 |
0.46 |
|
| 2009 |
Alcorn JL, Merritt TM, Farach-Carson MC, Wang HH, Hecht JT. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein. Rna (New York, N.Y.). 15: 686-95. PMID 19237461 DOI: 10.1261/Rna.1335909 |
0.31 |
|
| 2009 |
Oristian DS, Sloofman LG, Zhou X, Wang L, Farach-Carson MC, Kirn-Safran CB. Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 27: 28-35. PMID 18661500 DOI: 10.1002/Jor.20706 |
0.321 |
|
| 2009 |
Witt RL, Jia X, Liu C, Zhang C, Farach-Carson MC, Pradhan S. Engineering an Artificial Salivary Gland Otolaryngology–Head and Neck Surgery. 141: P50-P50. DOI: 10.1016/J.Otohns.2009.06.149 |
0.447 |
|
| 2008 |
Brown AJ, Alicknavitch M, D'Souza SS, Daikoku T, Kirn-Safran CB, Marchetti D, Carson DD, Farach-Carson MC. Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation. Bone. 43: 689-99. PMID 18589009 DOI: 10.1016/J.Bone.2008.05.022 |
0.626 |
|
| 2008 |
Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, ... Farach-Carson MC, et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309. PMID 18561328 DOI: 10.1002/Jcb.21785 |
0.398 |
|
| 2008 |
Farach-Carson MC, Brown AJ, Lynam M, Safran JB, Carson DD. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biology : Journal of the International Society For Matrix Biology. 27: 150-60. PMID 17997086 DOI: 10.1016/J.Matbio.2007.09.007 |
0.585 |
|
| 2008 |
D'Souza SS, Fazleabas AT, Banerjee P, Sherwin JR, Sharkey AM, Farach-Carson MC, Carson DD. Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biology of Reproduction. 78: 316-23. PMID 17989358 DOI: 10.1095/Biolreprod.107.063891 |
0.36 |
|
| 2008 |
Arnold RS, Chung LW, Farach-Carson MC, Huang W, Lue H, Marshall FF, Opdenaker L, Osunkoya AO, Petros JA, Rogatko A, Sung S, Tighiouart M, True LD, Vessella R, Wang R, et al. PROSTATE CANCER BONE METASTASIS: REACTIVE OXYGEN SPECIES, GROWTH FACTORS AND HEPARAN SULFATE PROTEOGLYCANS PROVIDE A SIGNALING TRIAD THAT SUPPORTS PROGRESSION Journal of Urology. 179: 192-192. DOI: 10.1016/S0022-5347(08)60558-3 |
0.716 |
|
| 2008 |
Schwarting-Opdenaker L, Carson D, Farach-Carson MC. P39. Rapamycin and the downstream target of mTOR, ribosomal protein L29 (RPL29), regulate prostate cancer cell growth and bone metastatic potential Cancer Treatment Reviews. 34: 70. DOI: 10.1016/J.Ctrv.2008.03.081 |
0.374 |
|
| 2007 |
Yeo H, Beck LH, Thompson SR, Farach-Carson MC, McDonald JM, Clemens TL, Zayzafoon M. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. The Journal of Biological Chemistry. 282: 35318-27. PMID 17884821 DOI: 10.1074/Jbc.M702435200 |
0.333 |
|
| 2007 |
O'Connor JC, Farach-Carson MC, Schneider CJ, Carson DD. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. Molecular Cancer Research : McR. 5: 585-603. PMID 17579118 DOI: 10.1158/1541-7786.Mcr-06-0408 |
0.416 |
|
| 2007 |
D'Souza SS, Daikoku T, Farach-Carson MC, Carson DD. Heparanase expression and function during early pregnancy in mice. Biology of Reproduction. 77: 433-41. PMID 17507691 DOI: 10.1095/Biolreprod.107.061317 |
0.306 |
|
| 2007 |
Farach-Carson MC, Carson DD. Perlecan--a multifunctional extracellular proteoglycan scaffold. Glycobiology. 17: 897-905. PMID 17442708 DOI: 10.1093/Glycob/Cwm043 |
0.353 |
|
| 2007 |
Casper CL, Yang W, Farach-Carson MC, Rabolt JF. Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding. Biomacromolecules. 8: 1116-23. PMID 17326680 DOI: 10.1021/Bm061003S |
0.307 |
|
| 2007 |
Rohe B, Safford SE, Nemere I, Farach-Carson MC. Regulation of expression of 1,25D3-MARRS/ERp57/PDIA3 in rat IEC-6 cells by TGF beta and 1,25(OH)2D3. Steroids. 72: 144-50. PMID 17188725 DOI: 10.1016/J.Steroids.2006.11.013 |
0.366 |
|
| 2006 |
Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, Pohl J, Hsieh CL, Weitzmann MN, Farach-Carson MC, Chung LW. beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Research. 66: 9108-16. PMID 16982753 DOI: 10.1158/0008-5472.Can-06-1996 |
0.413 |
|
| 2006 |
Yang W, Gomes RR, Brown AJ, Burdett AR, Alicknavitch M, Farach-Carson MC, Carson DD. Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Engineering. 12: 2009-24. PMID 16889529 DOI: 10.1089/Ten.2006.12.2009 |
0.584 |
|
| 2006 |
Muir C, Chung LW, Carson DD, Farach-Carson MC. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clinical & Experimental Metastasis. 23: 75-86. PMID 16826426 DOI: 10.1007/S10585-006-9021-2 |
0.387 |
|
| 2006 |
Gomes RR, Joshi SS, Farach-Carson MC, Carson DD. Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. Differentiation; Research in Biological Diversity. 74: 53-63. PMID 16466400 DOI: 10.1111/J.1432-0436.2005.00055.X |
0.343 |
|
| 2006 |
Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC. Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). American Journal of Physiology. Cell Physiology. 290: C822-31. PMID 16221734 DOI: 10.1152/Ajpcell.00403.2005 |
0.712 |
|
| 2005 |
Savorè C, Zhang C, Muir C, Liu R, Wyrwa J, Shu J, Zhau HE, Chung LW, Carson DD, Farach-Carson MC. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clinical & Experimental Metastasis. 22: 377-90. PMID 16283481 DOI: 10.1007/S10585-005-2339-3 |
0.388 |
|
| 2005 |
Shao Y, Alicknavitch M, Farach-Carson MC. Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 234: 54-62. PMID 16059921 DOI: 10.1002/Dvdy.20517 |
0.415 |
|
| 2005 |
Hecht JT, Hayes E, Haynes R, Cole WG, Long RJ, Farach-Carson MC, Carson DD. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes. Differentiation; Research in Biological Diversity. 73: 212-21. PMID 16026543 DOI: 10.1111/J.1432-0436.2005.00025.X |
0.334 |
|
| 2005 |
Rohe B, Safford SE, Nemere I, Farach-Carson MC. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS)-binding protein in rat IEC-6 cells. Steroids. 70: 458-63. PMID 15862831 DOI: 10.1016/J.Steroids.2005.02.016 |
0.373 |
|
| 2005 |
Farach-Carson MC, Hecht JT, Carson DD. Heparan sulfate proteoglycans: key players in cartilage biology. Critical Reviews in Eukaryotic Gene Expression. 15: 29-48. PMID 15831077 DOI: 10.1615/Critreveukaryotgeneexpr.V15.I1.30 |
0.303 |
|
| 2005 |
Yang WD, Gomes RR, Alicknavitch M, Farach-Carson MC, Carson DD. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds Tissue Engineering. 11: 76-89. PMID 15738663 DOI: 10.1089/Ten.2005.11.76 |
0.375 |
|
| 2005 |
Al-Shami R, Sorensen ES, Ek-Rylander B, Andersson G, Carson DD, Farach-Carson MC. Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. Journal of Cellular Biochemistry. 94: 1218-33. PMID 15696579 DOI: 10.1002/jcb.20379 |
0.742 |
|
| 2005 |
Shin H, Temenoff JS, Bowden GC, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials. 26: 3645-54. PMID 15621255 DOI: 10.1016/J.Biomaterials.2004.09.050 |
0.316 |
|
| 2005 |
Farach-Carson MC, Bergh JJ. Effects of 1,25-Dihydroxyvitamin D3 on Voltage-Sensitive Calcium Channels in the Vitamin D Endocrine System Vitamin D. 1: 751-760. DOI: 10.1016/B978-012252687-9/50047-4 |
0.628 |
|
| 2004 |
Farach-Carson MC, Bergh JJ, Xu Y. Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus. Steroids. 69: 543-7. PMID 15288767 DOI: 10.1016/J.Steroids.2004.05.002 |
0.694 |
|
| 2004 |
Nemere I, Safford SE, Rohe B, DeSouza MM, Farach-Carson MC. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. The Journal of Steroid Biochemistry and Molecular Biology. 89: 281-5. PMID 15225786 DOI: 10.1016/J.Jsbmb.2004.03.031 |
0.341 |
|
| 2004 |
Shin H, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. Journal of Biomedical Materials Research. Part A. 69: 535-43. PMID 15127400 DOI: 10.1002/Jbm.A.30027 |
0.332 |
|
| 2004 |
Nemere I, Farach-Carson MC, Rohe B, Sterling TM, Norman AW, Boyan BD, Safford SE. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells Proceedings of the National Academy of Sciences of the United States of America. 101: 7392-7397. PMID 15123837 DOI: 10.1073/Pnas.0402207101 |
0.362 |
|
| 2004 |
Kiefer J, Alexander A, Farach-Carson MC. Type I collagen-mediated changes in gene expression and function of prostate cancer cells. Cancer Treatment and Research. 118: 101-24. PMID 15043190 DOI: 10.1007/978-1-4419-9129-4_5 |
0.31 |
|
| 2004 |
Gomes RR, Farach-Carson MC, Carson DD. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells, Tissues, Organs. 176: 79-86. PMID 14745237 DOI: 10.1159/000075029 |
0.313 |
|
| 2004 |
Shin H, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials. 25: 895-906. PMID 14609678 DOI: 10.1016/S0142-9612(03)00602-1 |
0.307 |
|
| 2004 |
Bergh JJ, Xu Y, Farach-Carson MC. Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology. 145: 426-36. PMID 14525906 DOI: 10.1210/En.2003-0319 |
0.699 |
|
| 2003 |
Farach-Carson MC, Davis PJ. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. The Journal of Pharmacology and Experimental Therapeutics. 307: 839-45. PMID 14534365 DOI: 10.1124/Jpet.103.055038 |
0.317 |
|
| 2003 |
Bergh JJ, Shao Y, Akanbi K, Farach-Carson MC. Rodent osteoblastic cells express voltage-sensitive calcium channels lacking a gamma subunit. Calcified Tissue International. 73: 502-10. PMID 12958687 DOI: 10.1007/S00223-002-0016-Y |
0.712 |
|
| 2003 |
Miller SA, Brown AJ, Farach-Carson MC, Kirn-Safran CB. HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation; Research in Biological Diversity. 71: 322-36. PMID 12919102 DOI: 10.1046/J.1432-0436.2003.7106002.X |
0.596 |
|
| 2002 |
Swann SL, Bergh JJ, Farach-Carson MC, Koh JT. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. Organic Letters. 4: 3863-6. PMID 12599478 DOI: 10.1021/ol0266931 |
0.643 |
|
| 2002 |
Swann SL, Bergh J, Farach-Carson MC, Ocasio CA, Koh JT. Structure-based design of selective agonists for a rickets-associated mutant of the vitamin d receptor. Journal of the American Chemical Society. 124: 13795-805. PMID 12431109 DOI: 10.1021/Ja0268377 |
0.676 |
|
| 2002 |
Carson DD, Lagow E, Thathiah A, Al-Shami R, Farach-Carson MC, Vernon M, Yuan L, Fritz MA, Lessey B. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Molecular Human Reproduction. 8: 871-9. PMID 12200466 DOI: 10.1093/Molehr/8.9.871 |
0.733 |
|
| 2002 |
Ta TV, Baraniak D, Julian J, Korostoff J, Carson DD, Farach-Carson MC. Heparan sulfate interacting protein (HIP/L29) negatively regulates growth responses to basic fibroblast growth factor in gingival fibroblasts Journal of Dental Research. 81: 247-252. PMID 12097308 DOI: 10.1177/154405910208100405 |
0.302 |
|
| 2002 |
Farach-Carson MC, Xu Y. Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells. Steroids. 67: 467-70. PMID 11960622 DOI: 10.1016/S0039-128X(01)00168-4 |
0.391 |
|
| 2002 |
French MM, Gomes RR, Timpl R, Höök M, Czymmek K, Farach-Carson MC, Carson DD. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 17: 48-55. PMID 11771669 DOI: 10.1359/Jbmr.2002.17.1.48 |
0.315 |
|
| 2001 |
Kiefer JA, Farach-Carson MC. Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: Implications for enhanced growth in the bone microenvironment Matrix Biology. 20: 429-437. PMID 11691583 DOI: 10.1016/S0945-053X(01)00159-7 |
0.434 |
|
| 2001 |
Li W, Farach-Carson MC. Parathyroid hormone-stimulated resorption in calvaria cultured in serum-free medium is enhanced by the calcium-mobilizing activity of 1,25-Dihydroxyvitamin D3 Bone. 29: 231-235. PMID 11557366 DOI: 10.1016/S8756-3282(01)00572-5 |
0.349 |
|
| 2001 |
Farach-Carson MC. Bioactive analogs that simulate subsets of biological activities of 1α,25(OH)2D3 in osteoblasts Steroids. 66: 357-361. PMID 11179744 DOI: 10.1016/S0039-128X(00)00161-6 |
0.381 |
|
| 2000 |
Liu R, Xu Y, Farach-Carson MC, Vogel JJ, Karin NJ. 1,25 dihydroxyvitamin D3 activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca2+ Biochemical and Biophysical Research Communications. 273: 95-100. PMID 10873570 DOI: 10.1006/Bbrc.2000.2905 |
0.363 |
|
| 2000 |
Lecrone V, Li W, Devoll RE, Logothetis C, Farach-Carson MC. Calcium signals in prostate cancer cells: Specific activation by bone matrix proteins Cell Calcium. 27: 35-42. PMID 10726209 DOI: 10.1054/Ceca.1999.0083 |
0.419 |
|
| 2000 |
Liu R, Li W, Karin NJ, Bergh JJ, Adler-Storthz K, Farach-Carson MC. Ribozyme ablation demonstrates that the cardiac subtype of the voltage-sensitive calcium channel is the molecular transducer of 1, 25-dihydroxyvitamin D(3)-stimulated calcium influx in osteoblastic cells. The Journal of Biological Chemistry. 275: 8711-8. PMID 10722713 DOI: 10.1074/Jbc.275.12.8711 |
0.694 |
|
| 1999 |
French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DD. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. The Journal of Cell Biology. 145: 1103-15. PMID 10352025 DOI: 10.1083/Jcb.145.5.1103 |
0.377 |
|
| 1998 |
Safran JB, Butler WT, Farach-Carson MC. Modulation of osteopontin post-translational state by 1,25-(OH)2- vitamin D3: Dependence on Ca2+ influx Journal of Biological Chemistry. 273: 29935-29941. PMID 9792712 DOI: 10.1074/Jbc.273.45.29935 |
0.366 |
|
| 1998 |
Nemere I, Farach-Carson MC. Membrane receptors for steroid hormones: A case for specific cell surface binding sites for vitamin D metabolites and estrogens Biochemical and Biophysical Research Communications. 248: 443-449. PMID 9703943 DOI: 10.1006/Bbrc.1998.8492 |
0.329 |
|
| 1998 |
Farach-Carson MC, Ridall AL. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: Cross-talk between genomic and membrane-initiated pathways American Journal of Kidney Diseases. 31: 729-742. PMID 9531195 DOI: 10.1053/Ajkd.1998.V31.Pm9531195 |
0.392 |
|
| 1997 |
Snyder WR, Hoover J, Khoury R, Farach-Carson MC. Effect of agents used in perforation repair on osteoblastic cells. Journal of Endodontics. 23: 158-61. PMID 9594755 DOI: 10.1016/S0099-2399(97)80266-X |
0.342 |
|
| 1997 |
Li W, Duncan RL, Karin NJ, Farach-Carson MC. 1,25(OH)2D3 enhances PTH-induced Ca2+ transients in preosteoblasts by activating L-type Ca2+ channels American Journal of Physiology - Endocrinology and Metabolism. 273. PMID 9316451 DOI: 10.1152/Ajpendo.1997.273.3.E599 |
0.317 |
|
| 1997 |
Norman AW, Okamura WH, Hammond MW, Bishop JE, Dormanen MC, Bouillon R, van Baelen H, Ridall AL, Daane E, Khoury R, Farach-Carson MC. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Molecular Endocrinology (Baltimore, Md.). 11: 1518-31. PMID 9280067 DOI: 10.1210/Mend.11.10.9993 |
0.324 |
|
| 1996 |
Meszaros JG, Karin NJ, Farach-Carson MC. Voltage-sensitive calcium channels in osteoblasts: Mediators of plasma membrane signalling events Connective Tissue Research. 35: 107-111. PMID 9084649 DOI: 10.3109/03008209609029181 |
0.347 |
|
| 1996 |
Norman AW, Bishop JE, Collins ED, Seo EG, Satchell DP, Dormanen MC, Zanello SB, Farach-Carson MC, Bouillon R, Okamura WH. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. The Journal of Steroid Biochemistry and Molecular Biology. 56: 13-22. PMID 8603033 DOI: 10.1016/0960-0760(95)00219-7 |
0.333 |
|
| 1995 |
Pinero GJ, Farach-Carson MC, Devoll RE, Aubin JE, Brunn JC, Butler WT. Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, alpha 2HS-glycoprotein and alkaline phosphatase. Archives of Oral Biology. 40: 145-55. PMID 7794128 DOI: 10.1016/0003-9969(94)00144-Z |
0.345 |
|
| 1995 |
Khoury RS, Weber J, Farach-Carson MC. Vitamin D metabolites modulate osteoblast activity by Ca+2 influx- independent genomic and Ca+2 influx-dependent nongenomic pathways Journal of Nutrition. 125. PMID 7782930 DOI: 10.1093/Jn/125.Suppl_6.1699S |
0.361 |
|
| 1994 |
Bronckers ALJJ, Farach-Carson MC, Van Waveren E, Butler WT. Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat Journal of Bone and Mineral Research. 9: 833-841. PMID 8079659 DOI: 10.1002/Jbmr.5650090609 |
0.387 |
|
| 1994 |
Khoury R, Ridall AL, Norman AW, Farach-Carson MC. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx Endocrinology. 135: 2446-2453. PMID 7988430 DOI: 10.1210/Endo.135.6.7988430 |
0.361 |
|
| 1993 |
Mckee MD, Farach-Carson MC, Butler WT, Hauschka PV, Nanci A. Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and α2HS-glycoprotein) proteins in rat bone Journal of Bone and Mineral Research. 8: 485-496. PMID 8475798 DOI: 10.1002/Jbmr.5650080413 |
0.332 |
|
| 1993 |
Farach-Carson MC, Abe J, Nishii Y, Khoury R, Wright GC, Norman AW. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways. The American Journal of Physiology. 265: F705-11. PMID 8238551 DOI: 10.1152/Ajprenal.1993.265.5.F705 |
0.369 |
|
| 1992 |
D'Souza RN, Bronckers ALJJ, Happonen RP, Doga DA, Farach-Carson MC, Butler WT. Developmental expression of a 53 KD dentin sialoprotein in rat tooth organs Journal of Histochemistry and Cytochemistry. 40: 359-366. PMID 1552175 DOI: 10.1177/40.3.1552175 |
0.351 |
|
| 1992 |
Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, Collins ED, Taoka T, Sergeev I, Farach-Carson MC. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways Journal of Steroid Biochemistry and Molecular Biology. 41: 231-240. PMID 1314073 DOI: 10.1016/0960-0760(92)90349-N |
0.347 |
|
| 1991 |
Farach-Carson MC, Sergeev I, Norman AW. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: Structure-function studies using ligand analogs Endocrinology. 129: 1876-1884. PMID 1655387 DOI: 10.1210/Endo-129-4-1876 |
0.373 |
|
| 1989 |
Farach-Carson MC, Carson DD, Collier JL, Lennarz WJ, Park HR, Wright GC. A calcium-binding, asparagine-linked oligosaccharide is involved in skeleton formation in the sea urchin embryo. The Journal of Cell Biology. 109: 1289-99. PMID 2475510 DOI: 10.1083/Jcb.109.3.1289 |
0.333 |
|
| Show low-probability matches. |